Skip to content

Clinical trials

Hepatitis, Chronic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis, Chronic Country / region: United Kingdom Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20091
20121
20131
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Pharmasset2
AusperBio Therapeutics Inc.1
Gilead Sciences1
Janssen Pharmaceutica N.V., Belgium1
Novartis Pharmaceuticals1
nChroma Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis, Chronic9
Hepatitis B6
Hepatitis5
Hepatitis B, Chronic5
Digestive System Diseases3
Hepatitis, Viral, Human3
Liver Diseases3
Virus Diseases3
DNA Virus Infections2
Blood-Borne Infections1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.